Stem Cell Research Now and in the Future

November 2009. November 2009. “Stem cells provide novel opportunities that didn't previously exist” says Patrick Vallance, President Pharmaceuticals, R&D of GlaxoSmithKline in the interview with B2Bioworld. He describes his company’s approach. What is the role of cancer stem cells? What about novel drugs like lapatinib or trastuzumab? Which collaborations are desirable? The interview includes stem cell issues yet unattended by pharma.

Includes Tumour Therapy Basic Approaches; detailed chart: GSK Partnering Capabilities

Reading time: 5 min

Read Now:
1,00 EUR (incl. 7% VAT)

Back to section